ACCESS Newswire•5 days agoBioInvent Announces Publication of Preclinical Manuscript on BI-1808 and BI-1910 in Cancer ResearchBINV.ST0.00%
ACCESS Newswire•18 days agoBioInvent Receives FDA Fast Track Designation for BI-1808 for the Treatment of Ovarian CancerBINV.ST0.00%